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Abstract
Background: A major challenge in pancreatic cancer treatment is the resistance of human pancreatic cancer cells
to apoptosis. Soy isoflavones and calpain inhibition have been suggested to exert inhibitory effects on cancer
development and progression. We investigated the effects of the isoflavone containing beverage Haelan 951 and
the calpain inhibitor PD150606 on the viability, growth and apoptosis of the human pancreatic cancer cell lines
CAPAN-1 and BxPC-3, on the rat pancreatic cancer cell line AR42J, and on human fibroblasts as the control cell line.
Methods: Cellular viability and proliferation were determined using the LDH cytotoxicity and WST-1 assay, respectively.
Apoptosis was detected by flow cytometric analyses of Annexin V-FITC labeled-cells, TUNEL assay and caspase
activation. Student’s t test or Mann–Whitney Rank Sum test were used to compare the data.
Results: Haelan concentrations lower than 8 % showed no cytotoxic effects, whereas higher concentrations led to
necrosis. Eight percent Haelan induced significant growth inhibition of CAPAN-1 and BxPC-3 cell lines by 30 % and
35 %, respectively, compared with the control. The proliferation rate of AR42J cells decreased by 50 %, whereas the
fibroblasts remained unaffected. An 1.1-fold increase in apoptosis was found in CAPAN-1 cells, whereas the number of
apoptotic BxPC-3 cells was elevated 2-fold. The number of apoptotic AR42J cells and fibroblasts was elevated 1.5-fold,
each. Inhibition of calpain activity amplified the Haelan-induced growth inhibition of CAPAN-1 and BxPC-3 cells, but
failed to amplify the growth inhibition of Haelan-treated AR42J cells. In fibroblasts, calpain inhibition induced
Haelan-independent growth inhibition. Calpain inhibition also amplified the Haelan-induced apoptotic activity in all
cancer cell lines, but exerted no further effect in fibroblasts.
Conclusions: The proliferation-inhibiting and apoptosis-inducing effects of Haelan are highly dependent on cell type
and concentration administered. The results show for the first time that Haelan may be a promising candidate in the
treatment of human pancreatic cancer, and its anticancer activity may be potentiated when administered with calpain
inhibitors.
Background
The most common type of pancreatic cancer (PC) is the
highly aggressive adenocarcinoma originating from the
exocrine pancreas. PC is the fourth most common cause
of cancer-related mortality in the US and Europe with a
5-year survival of just 4 % [1, 2]. The high mortality and
dismal survival rate both strongly suggest that the evalu-
ation of therapeutic agents is urgently needed. A major
challenge in the treatment of PC has been the lack of
protective responses to various chemotherapies, which
has been attributed to the resistance of PC cells to apop-
tosis [3]. Thus, increasing the sensitivity of tumor cells
to apoptosis may be a promising strategy for the devel-
opment of efficient chemotherapies that extend survival.
Apoptosis is defined as a programmed form of cell
death induced to eliminate genetically altered cells
without causing severe host reaction. Apoptosis can be
induced by various extracellular and intracellular stim-
uli leading to the activation of three main pathways,
the extrinsic (death receptor-mediated), the intrinsic
(mitochondrial) and the endoplasmic reticulum stress-
mediated pathway. An increasing number of studies
suggests that naturally occurring compounds may be
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suitable candidates for cancer treatment by inducing
apoptosis, such as bufalin, a component of the Chinese
herbal medicine Chan-Su, the 4-herb Chinese medicine
formulation PHY906, the traditional Chinese medicine
herbal mixture LQ, and [6]-gingerol, a ginger phytochem-
ical [4–7]. Isoflavones, a subclass of naturally occurring
and biologically active polyphenolic phyto-estrogens, have
also been shown to possess anticancer activities. They de-
regulate cell cycle progression, induce apoptosis, function
as antioxidants, modulate multiple cell signalling pathways
and inhibit tumor invasion [8]. Isoflavones are found in
plant-derived foods and beverages such as vegetables,
fruits, green tea and wine [9, 10]. A very rich source of
isoflavones is the soybean, containing the predominant
glycoside compounds genistin and daidzin along with
other glycosides [10]. Fermentation of soy hydrolyzes the
glycosides to form isoflavone aglycones such as genistein,
daidzein and others that are absorbed faster and in greater
amounts than their glucosides upon oral administration in
humans [11].
Several studies on a variety of cancer cell lines suggest
that a mixture of isoflavones is more effective in sup-
pressing cancer growth than the isolated compounds
alone [12–15]. Thus, in the present study, we investi-
gated the anticancer effect of the commercially available
fermented soy beverage, Haelan 951 (Hael), mainly con-
tains genistein, genistin, and daidzein using the human
PC cell lines, BxPC-3 and CAPAN-1, the rat PC cell line,
AR42J, and human fibroblasts as control to detect cyto-
toxic activity to non-cancer cells [16]. A further aim was
to investigate whether inhibition of calpain may amplify
Hael-induced anticancer activity. Calpains are a family
of cytosolic neutral cysteine proteases that are strictly
controlled by the cytosolic Ca2+ concentration and the
endogenous inhibitor protein, calpastatin. Calpain, in
particular the ubiquitous isoforms μ- and m-calpain, has
been identified to be involved in cancer development
and progression, including cell transformation, migration
and tumor invasion, apoptosis/survival, as well as angio-
genesis via signal-dependent limited cleavage of its
substrates [17, 18].
Our results show for the first time that Hael may be a
promising agent in the treatment of human pancreatic
cancer, leading to growth arrest and apoptosis without
cytotoxic effects. Inhibition of the calpain activity was
found to improve the therapeutic efficacy of Hael.
Methods
Reagents
Haelan 951 Platinium Formula (Hael) (batch no. 4050901)
was purchased from Haelan Products, Inc. Woodinville,
WA, U.S.A.). The beverage contains 555 μM diadzein
and 955 μM genistein [16]. Cell proliferation reagent
WST-1 and the TUNEL (terminal deoxynucleotyl
transferase-mediated dUTP nick end labelling) assay
were purchased from Roche (Mannhein, Germany).
Penicillin and streptomycin were obtained from Bio-
chrom Seromed (Berlin, Germany). 3-(4-Iodophenyl)-
2-mercapto-(Z)-2-propenoic acid (PD150606) and 1,
2-Bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetox
ymethylester (BAPTA-AM) were purchased from
Calbiochem-Novabiochem (Nottingham, UK). Accutase
was obtained from Millipore Corp. (Temecola, CA,
U.S.A.). FBS (heat inactivated) and all other cell culture
material were obtained from Life Technologies (Paisley,
UK). The CytoGlo Annexin V-FITC Apoptosis Detection
Kit was purchased from IMGENEX (San Diego, CA,
U.S.A).
Cell cultures
The human pancreatic carcinoma cell lines BxPC-3 and
CAPAN-1, the rat pancreatic carcinoma cell line AR42J
and the human skin fibroblast cell line were obtained
from the American Type Culture Collection (Rockville,
MD, U.S.A.) The AR42J cells and the fibroblasts were
grown in DMEM supplemented with 10 % (v/v) FCS.
The CAPAN-1cell line was grown in IMDM supple-
mented with 10 % (v/v) FBS. The BxPC-3 cell line was
cultured in RPMI containing 10 % (v/v) FBS. All culture
media were supplemented with 50 U/ml penicillin and
50 μg/ml streptomycin. The cells were grown at 37 °C in
a 5 % CO2 humidified atmosphere. Growing cells were
checked for viability and confluence by light microscopy.
The cells were detached by accutase according to the
manufacturer’s recommendation.
Exposure of PC cell lines and fibroblasts to increasing
concentrations of Hael
The three PC cell lines and human fibroblasts (pro well:
4 x 104 cells / 2 ml cell culture medium) were added to
24-well plates including the control and blank. After
reaching subconfluence, the medium was removed and
the cells were incubated with increasing concentrations of
Hael (2 % - 32 %) containing in 2 ml of the corresponding
cell culture medium for 24 and 48 h. The control cells
were incubated with medium only.
Exposure of PC cell lines and fibroblasts to 8 % Hael in
combination with calpain inhibitors
The three PC cell lines and human fibroblasts (4 x 104
cells/2 ml cell culture medium) were incubated with 8 %
Hael in the presence or absence of the calpain inhibitor
PD150606 (20 μM) or the Ca2+ chelator BAPTA-AM
(10 μM) for 24 h. The inhibitors were dissolved in DMSO
for a final concentration of 1 %. Control and Hael-treated
cells without inhibitor were incubated with vehicle.
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Determination of cellular viability
After termination of the experiment, cell membrane
damage was assessed by measuring the release of lactate
dehydrogenase (LDH) into the incubation medium using
the LDH test kit and Synchron LX 20 analyzer from
Beckman Coulter (Krefeld, Germany).
Cell proliferation assay
To characterize cellular proliferation rate, the WST-1
assay was used. The WST-1 assay is based on the cleav-
age of the tetrazolium salt WST-1 in viable cells only,
leading to the formation of a soluble formazan salt,
which can then be measured photometrically. After ter-
mination of the cell culture experiment, the cells were
washed twice with PBS, and 50 μl WST-1 in 500 μl cell
culture medium was added. After 2 h, the absorbance
was measured at 450/600 nm using a Benchmark Plus
microplate reader (BioRad, Munich, Germany).
Detection of apoptotic cells by the in situ cell death
detection kit, POD
Apoptosis leads to cleavage of genomic DNA. For apop-
tosis detection, these strand breaks can be identified by
labeling free 3’-OH termini with modified nucleotides in
an enzymatic reaction using the in situ cell death detec-
tion kit, POD. Cells were cultured in culture slides (BD
Biosciences, Bedford, MA, U.S.A.) and incubated with or
without 8 % Hael for 24 h. Thereafter, they were fixed
with fixation solution for 2 min on ice. In the next step,
50 μl TUNEL-POD was added. The chamber was closed
and incubated for 30 min at 37 °C. After three washing
steps with PBS, 50 μl substrate solution was added
which was followed by a 10 min incubation period at
RT. Thereafter, the cells were visualized under a trans-
mission light microscope.
Quantification of apoptosis using the CytoGlo Annexin
V-FITC Apoptosis Detection Kit
Cells were harvested, pelleted by centrifugation and
washed twice with PBS. Aliquots of 1 x 106 cells were
suspended in 100 μl binding buffer (10 mM HEPES,
135 mM NaCl, 5 mM CaCl2) followed by the addition
of 5 μl staining reagent. After incubation in the dark at
RT for 20 min, 400 μl binding buffer was added, and
the cells were analyzed using a flow cytometer (Becton
Dickinson, Heidelberg, Germany, excitation: 488 nm;
emission: 530 nm; software version 1.2). Ten thousand
events were measured per sample.
Detection of apoptosis by SR-FLICA multicaspase assay
Apoptosis was detected using the sulforhodamine FLICA
(Fluorescent Labeled Inhibitors of Caspases) apoptosis de-
tection kit containing sulforhodamyl-L-valylalanylaspartyl
fluoromethyl ketone (SR-VAD-FMK). The FLICA reagent
is cell permeable and non-toxic. It reacts covalently with
activated caspases and is retained in apoptotic cells, while
unbound reagent will diffuse out of the cell.
Aliquots of 105 cells were seeded onto chamber slides
and grown in their respective cell culture media at 37 °C
for 24 h. Then, cells were incubated with 8 % Hael for
24 h followed by application of FLICA solution accord-
ing to the manufacturer’s recommendation. After 1 h in-
cubation at 37 °C in 5 % CO2 environment, the medium
was removed and DAPI (1.5 μl per 300 μl medium) was
added followed by an additional 5 min incubation
period. Finally, the cells were observed under a fluores-
cence microscope Nikon Eclipse E600 using a band pass
filter (excitation 510–560 nm, emission 590 nm for red
fluorescence) and an UV-filter (excitation 340–380 nm,
emission 435–485 nm for DAPI stain). The intensity of
the red fluorescence correlates with the concentration of
activated caspases.
Statistical methods
Data are expressed as means + SEM. Mean values of
normally distributed data with equal variance were com-
pared by Student`s t test. If the normality test failed, the
data were compared by Mann–Whitney Rank Sum test.
The statistical software package SigmaStat 3.5 from Jandel
Corporation (Erkrath, Germany) was used. P ≤ 0.05 was
considered as statistically significant.
Results
Effects of different Hael concentrations on the viability of
PC cell lines and fibroblasts
The human PC cell lines CAPAN-1 and BxPC-3, the rat
PC cell line AR42J and human fibroblasts were incu-
bated with Hael at concentrations ranging from 2 % to
32 % for 24 h (Fig. 1a-d). Cellular viability was deter-
mined by measuring the LDH release into the incuba-
tion medium. At concentrations of 2 %, 4 % and 8 %,
Hael induced no cytotoxic effects in any of the cell lines
investigated. However, at a concentration of 16 % Hael,
significant damage of the plasma membrane was ob-
served, leading to an increase in the LDH release by
87 % in CAPAN-1 cells, 80 % in BxPC-3 cells (P < 0.05),
and by 100 % each in AR42J cells (P < 0.1) and fibroblasts
(P < 0.05), versus corresponding control. In response to
32 % Hael, a further dramatic increase in cell damage was
recorded in all cell lines investigated, particularly in the
BxPC-3 cells.
Effects of different Hael concentrations on the
proliferation of PC cell lines and fibroblasts
To investigate the effect of Hael on cellular proliferation,
the activity of mitochondrial dehydrogenases was mea-
sured using the WST-1 assay (Fig. 2a-d). Concentrations
of 2 % and 4 % Hael induced a significant increase in the
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proliferation of CAPAN-1 cells by approximately 60 %
in comparison with the control (P < 0.05). A small in-
crease in proliferation was also observed on the fibro-
blasts using these concentrations. In AR42J cells,
however, concentrations of 2 % and 4 % Hael signifi-
cantly reduced the proliferation rate. The proliferation
rate of BxPC-3 cells at 2 % and 4 % Hael tended to be
reduced, although the results were non-significant.
Exposure to 8 % Hael significantly reduced the prolif-
eration rate of all PC cell lines but not of fibroblasts. In
particular, the proliferation of CAPAN-1 and BxPC-3 cells
was decreased by 30 % (P < 0.001) and 35 % (P < 0.001),
respectively. The AR42J cell line displayed a decrease in
proliferation rate by 50 % (P < 0.001) when treated with
8 % Hael. Treatment with 16 % or 32 % Hael induced
strong cytotoxic effects in all cell lines investigated. Based
on these results, a concentration of 8 % Hael was chosen
for further experiments.
Effect of 8 % Hael on the proliferation of PC cell lines and
fibroblasts at different incubation times
Incubating the cell lines with 8 % Hael for 48 h caused
no further decrease in the proliferation rate of CAPAN-1
cells, AR42J cells and fibroblasts when compared to the
proliferation rate measured after 24 h (Fig. 3). However,
the proliferation of BxPC-3 cells was reduced by 35 %
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Fig. 1 Dose-dependent effect of Haelan on the viability of pancreatic carcinoma cells and fibroblasts. CAPAN-1 cells (a), BxPC-3 cells (b), AR42J
cells (c) and fibroblasts (d) were incubated with or without increasing concentrations of Haelan. After 24 h, cellular viability was assessed using
the LDH cytotoxicity assay. Haelan concentrations of 2 %-8 % induce no cytotoxic effects, whereas concentrations higher than 8 % cause significant
plasma membrane damage in all cell lines investigated. The results are expressed as mean + SEM (n = 3-12). +P < 0.1, *P < 0.05, **P < 0.01, control vs.
Haelan-treated cells
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Effect of 8 % Hael on apoptosis in PC cells and fibroblasts
To examine whether Hael causes apoptosis, cells were
stained with Annexin V-FITC and flow cytometric ana-
lyses were undertaken after 24 h. In CAPAN-1 cells, 8 %
Hael increased the number of Annexin V-positive cells
1.1-fold, and in BxPC-3 cells 2.1-fold (P < 0.05) com-
pared to the corresponding control (Fig. 4a, b). The
number of apoptotic AR42J cells and fibroblasts was
increased by a factor of 1.5 each (P < 0.01 and P < 0.05),
respectively, (Fig. 4c, d).
Using the TUNEL POD assay for apoptosis detection,
the results also revealed that 8 % Hael induced apoptosis
in all cell lines investigated. Thus, in the CAPAN-1 cell
population, only a small number of apoptotic cells (stained
dark brown) was visible compared with the control,
whereas in all other cell lines, the number of apoptotic
cells was of greater degree (Fig. 5a-h).
To investigate whether caspase activation may be
involved in Hael-induced apoptosis, cells were dually
stained with SR-VAD-FMK reagent and DAPI, and
viewed through a fluorescence microscope. Cells exhibit-
ing a very bright red staining patter were undergoing
apoptosis in a caspase-dependent manner, whereas cells
appearing faint red were just in early apoptotic stage.
Compared with the corresponding control groups, a
greater number of red-colored cells was found in the
Fig. 2 Effect of Haelan on the proliferation of pancreatic carcinoma cells and fibroblasts. CAPAN-1 cells (a), BxPC-3 cells (b), AR42J cells (c) and
fibroblasts (d) were incubated with or without increasing concentrations of Haelan. After 24 h, the proliferation was measured using the WST-1
assay. Haelan exerts significant effects on cell proliferation dependent upon cell type and concentration. The concentration of 8 % Haelan induces
growth arrest in all pancreatic cancer cells, but not in the fibroblasts. The results are expressed as mean + SEM (n = 3-12). *P < 0.05, ***P < 0.001,
control vs. Haelan-treated cells
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Hael-treated CAPAN-1 cells (compare Fig. 6a, b), in
Hael-treated BxPC-3 cells (compare Fig. 6c, d), in Hael-
treated AR42J cells (compare Fig. 6e, f ) and in Hael-
treated fibroblasts (compare Fig. 6g, h).
Effect of calpain inhibition and cytosolic Ca2+ binding on
cellular viability and growth inhibition of Hael-treated PC
cells and fibroblasts
We first tested whether treatment of cell lines with the
specific calpain inhibitor PD150606 or the Ca2+ chelator
BAPTA-AM in combination with 8 % Hael lead to cellu-
lar damage. As assessed by the LDH cytotoxicity assay,
no cytotoxic effects were found when the cells were in-
cubated with Hael in the presence of PD150606 in com-
parison with Hael treatment alone (Fig. 7a-d). Exposure
to Hael in the presence of BAPTA-AM increased the
LDH release of CAPAN-1 and BxPC-3 cells but not of
AR42J cells and fibroblasts.
Next, we investigated the effect of PD150606 or
BAPTA-AM on cell proliferation. Compared to Hael
treatment alone, co-incubation of CAPAN-1 and BxPC-
3 cells with Hael and PD150606 caused an additional
reduction in the proliferation by 15 % (P < 0.01) and 25 %
(P < 0.05), respectively (Fig. 8a, b). No further reduction
in Hael-induced growth inhibition was observed in
AR42J cells (Fig. 8c). Interestingly, whereas Hael exhib-
ited no inhibitory effect on the proliferation rate of
fibroblasts, a small but significant decrease (P < 0.05) was
observed under combined treatment with PD150606
(Fig. 8d).
Cytosolic Ca2+ binding by BAPTA-AM also affected
cell proliferation. BAPTA-AM inhibited Hael-induced
proliferation rate in CAPAN-1 cells by 50 % (P < 0.001),
and in BxPC-3 cells by 70 % (P < 0.001), (Fig. 8a, b).
In AR42J cells, BAPTA-AM failed to further decrease
Hael-induced growth inhibition, but caused a Hael-
independent growth inhibition in fibroblasts by approxi-
mately 30 % (P < 0.01) compared to Hael treatment alone
(Fig. 8c, d).
Effect of calpain inhibition and cytosolic Ca2+ binding on
Hael-induced apoptosis in PC cell lines and fibroblasts
Co-treatment of Hael with PD150606 or BAPTA-AM
increased the number of apoptotic CAPAN-1 cells 1.2-fold
and 1.3-fold, respectively, when compared to Hael-
treatment alone (Fig. 4a). A stronger amplification of
Hael-induced apoptosis was achieved in the other PC
cell lines. Thus, in BxPC-3 cells, treatment of Hael to-
gether with PD150606 or BAPTA-AM increased the
number of apoptotic cells 1.9-fold (P < 0.05) and 4.8-
fold (P < 0.05), whereas in AR42J cells, an additional
increase by 1.1-fold (P < 0.05) and 1.4-fold (P < 0.05)
was observed, respectively, (Fig. 4b, c). In fibroblasts,
however, neither PD150606 nor BAPTA-AM amplified
the degree of Hael-induced apoptosis (Fig. 4d).
Discussion
In this study, we investigated the effect of the fermented
soy-based beverage Hael 951 on cell viability, prolifera-
tion and apoptosis in human and rat PC cell lines and
human fibroblasts. Hael 951 is rich in soybean proteins,
flavonoids, selenium, zinc, and vitamin A, B2, B12, C, D3,
E and K. In addition, it contains essential fatty acids such
as linolenic and linoleic acids [19]. Our results suggest
that the effect of Hael strongly depends on concentration
and cell type. Thus, we found that lower concentrations of
2 % and 4 % Hael stimulated the proliferation of human
CAPAN-1 cells and fibroblasts within the 24 h observation
period but not the proliferation of AR42J and BxPC-3
cells. The stimulating effect may be due to genistein and
daidzein, which are two of the major components of Hael.
Both compounds have been reported to increase the
proliferation of prostate epithelial and estrogen-sensitive
human breast cancer (MCF-7) cells, but not of estrogen-
insensitive human breast cancer (MDA-MB-231) cells
[20–22]. In MCF-7 cells, this effect has been attributed
to an increase in DNA synthesis [23]. CAPAN-1 cells
and fibroblasts are estrogen receptor-expressing cells as
well [24, 25]. Consequently, Hael-induced increase in
the proliferation rate of these cell lines may also be ex-
plained with an increase in DNA synthesis. In human
BxPC-3 and rat AR42J cells, the low Hael concentra-
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Fig. 3 Time-dependent effect of Haelan on the proliferation of
pancreatic carcinoma cells and fibroblasts. CAPAN-1 cells, BxPC-3 cells,
AR42J cells and fibroblasts were incubated with or without 8 % Haelan.
After 24 h and 48 h, cell proliferation was measured using the WST-1
assay. Haelan induces a reduction in the proliferation of the pancreatic
cancer cells, but not of the fibroblasts after 24 h. The proliferation of
the cancer cells shows no reduction after 48 h with the exception of
BxPC-3 cells. The results are expressed as mean + SEM (n = 6-12)
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In response to higher (8 %) concentrations of Hael, the
inhibitory effect on cellular proliferation was magnified,
leading to significant growth arrest in all cancer cell lines
investigated. The proliferation of fibroblasts was not af-
fected by 8 % Hael. In support of these findings, the cor-
responding LDH activities measured in parallel were
unchanged, suggesting that the decrease in the WST-1
levels was not caused by cell membrane damage, but
reflects genuine growth inhibition. The finding that the
proliferation of BxPC-3 cells was further reduced after
48 h, whereas a similar effect was not found in the other
cancer cell lines may indicate that BxPC-3 cells were of
higher sensitivity to Hael.
Hael concentrations higher than 8 %, such as 16 % and
32 %, dramatically reduced the WST-1 levels in the can-
cer cell lines as well as in fibroblasts. These findings
were accompanied by increased corresponding LDH re-
leases, suggesting that higher Hael concentrations do
not induce growth arrest but exert strong cytotoxic
effects. Similarly, high concentrations of the major Hael
component genistein have been reported to cause dam-
age to various cell types, including the human ovarian
cancer cell line SK-OV-3, and primary rat cortical neu-
rons [12, 26, 27]. Genistein was also shown to dramatic-
ally reduce the number of the pancreatic CAPAN-1,




























































































































Fig. 4 Haelan-induced apoptosis in pancreatic carcinoma cells and fibroblasts. CAPAN-1 cells a, BxPC-3 cells b, AR42J cells c and fibroblasts d
were incubated with 8 % Haelan or vehicle in the presence or absence of the calpain inhibitor PD150606 or Ca2+ chelator BAPTA-AM and stained
after 24 h using the CytoGlo Annexin V-FITC Apoptosis Detection kit. The percentages of Annexin V-positive cells are assessed by flow cytometric
analyses. Haelan induces apoptosis in all cell types investigated. PD150606 or BAPTA-AM increases the degree of Haelan-induced apoptosis in all
cells with the exception of the fibroblasts. The results are expressed as mean + SEM (n = 3-4). *P < 0.05, **P < 0.01, control vs. Haelan-treated cells,
xP < 0.05, Haelan-treated cells vs. cells treated with Haelan in the presence of PD150606 or BAPTA-AM
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component, daidzein, caused damage to HeptG2 cells
and primary rat cortical neurons when administered in
high concentrations [27, 29]. Based on these results, fur-
ther experiments were performed with 8 % Hael. This
concentration is approximately 100-fold higher than that
found in the plasma samples obtained from a patient 1 h
after ingesting 4-oz of Hael [16].
Investigating the apoptosis-inducing activity, the re-
sults show that 8 % Hael induces apoptosis in all PC
cells and fibroblasts, in which the CAPAN- 1 cells
showed the lowest sensitivity to 8 % Hael, and the
BxPC-3 cells the highest sensitivity. In addition, the
results also reveal that the cells entered the apoptotic
pathway in a caspase-dependent manner.
Concerning the molecular mechanisms underlying
Hael-induced growth arrest and apoptosis, several expla-
nations can be offered. Flavonoids including genistein
and daidzein have been shown to induce DNA damage
via inhibition of tyrosine kinases and topoisomerase-II,
which in turn may lead to activation of p53 tumor-
suppressor protein-dependent pathways [30, 31]. Low
levels of p53 induced in response to low or repairable
stress have been observed to result in cell cycle arrest
leading to expression of survival genes that are able to
repair any cell damage [32]. The precise point within the
cell cycle the flavonoids block seems to be dependent on
their concentration, the exposure time, the experimental
conditions, and the cell line investigated [33]. Irreparable
DNA damage leads to higher p53 expression that initi-
ates apoptosis to prevent the propagation of genetic de-
fects to successive generations of cells [32]. The extent
of p53-dependent gene expression has been identified to
be cell line-specific as well [34].
In further experiments, we show that inhibition of the
calpain activity improves the therapeutic efficacy of Hael.












Fig. 5 Haelan-induced apoptosis in pancreatic carcinoma cell lines and fibroblasts. CAPAN-1 cells (a, b), BxPC-3 cells (c, d), AR42J cells (e, f) and
fibroblasts (g, h) were grown on culture slides and treated with or without 8 % Haelan for 24 h. For apoptosis detection, the TUNEL assay was
used. The light micrographs demonstrate that Haelan causes apoptosis in all cell types investigated when compared with the respective controls.
(n = 2; original magnification x10; arrows indicate apoptotic cells)
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calpain inhibitor PD150606, which does not block other
proteases, the results show a significant amplification of
Hael-induced growth inhibition in CAPAN-1 and BxPC-
3 cells and a downward trend in the AR42J cell prolifera-
tion rate. Interestingly, Hael alone failed to induce
growth arrest in fibroblasts as already mentioned above,
but simultaneous inhibition of calpain led to a small in-
hibitory effect on proliferation. A variety of studies have
shown that p53 is a calpain substrate [35]. Consequently,
inhibition of calpain activity may lead to growth arrest
by increasing the availability of p53 [36]. Furthermore,
calpain has been shown to regulate the cell cycle at
multiple points [18]. In cancer cells, the protease
cleaves inhibitors of cyclin-dependent kinases p21/
Cip1 and p27/Kip1, which in turn facilitates cell prolif-
eration [17, 37]. Therefore, inhibition of calpain activ-
ity may lead to growth arrest.
Investigating the effect of calpain inhibition on Hael-
induced apoptotic activity, our results reveal an increase
in Annexin V-positive cells in all PC cell populations
investigated. Western blot analyses of active caspase-3
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Fig. 6 Haelan-induced apoptosis in pancreatic carcinoma cells and fibroblasts. CAPAN-1 cells a, b, BxPC-3 cells c, d, AR42J cells e, f and fibroblasts
g, h were incubated with or without 8 % Haelan and dually stained with sulforhodamine-labeled caspase inhibitor, SR-VAD-FMK, and DAPI. The
representative micrographs demonstrate only few red-colored apoptotic cells in the control groups and a much greater number of red-colored
apoptotic cells in the Haelan-treated groups when analyzed after 24 h (n = 2); (original magnification x 10)
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our data, inhibition of the calpain activity has been ob-
served to initiate apoptosis in a variety of cancer cell
lines, including human prostate tumor cells, hepatocellu-
lar tumor cells (SK-HEP-1, HLF), colorectal cancer cells
(RKO, DLD-1), Jurkat and Molt cells [36, 38–40]. There
is growing evidence suggesting that calpain cleaves up-
stream caspases including caspase-3, −8 and −9 leading
to inactivation of apoptosis [36, 40, 41]. Consequently,
inhibition of calpain activity should lead to activation of
apoptosis as observed in the present study. In Hael-
treated fibroblasts, however, calpain inhibition failed to
enhance apoptosis, suggesting that the underlying mo-
lecular mechanisms are different between non-cancer
and cancer cells.
The observation that BAPTA-AM amplified the Hael-
induced growth inhibition in all PC cell lines and pro-
voked growth inhibition in Hael-treated fibroblasts indi-
cates that Ca2+-dependent mechanisms may contribute
to the regulation of cancer cell and non-cancer cell
proliferation alike. BAPTA-AM-induced cytosolic Ca2+
binding also increased the apoptotic activity of Hael in
CAPAN-1, BxPC-3 and AR42J cells, but failed to en-
hance Hael-induced apoptosis in fibroblasts. S100 pro-
teins, which are a large family of Ca2+ binding proteins
of the EF-hand type, may be involved in these observa-
tions. S100 proteins have been reported to play a role in
the regulation of numerous processes, including prolifera-
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Fig. 7 Effect of calpain inhibition and cytosolic Ca2+ binding on the viability of Haelan-treated pancreatic carcinoma cells and fibroblasts. CAPAN-1 cells a,
BxPC-3 cells b, AR42J cells c and fibroblasts d were incubated with 8 % Haelan or vehicle in the presence or absence of the calpain inhibitor
PD150606 or the Ca2+ chelator BAPTA-AM. After 24 h, the cellular viability was assessed using the LDH cytotoxicity assay. Inhibition of calpain
activity or Ca2+ chelation has no effect on the viability of Haelan-treated pancreatic carcinoma cells and fibroblasts. The results are expressed
as mean + SEM (n = 3-7)
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metabolism, inflammation and migration/invasion [42].
Upon Ca2+ binding, most S100 proteins undergo a con-
formational change that enables them to interact with
their target proteins [43]. Thus, binding of cytosolic Ca2+
by BAPTA-AM may prevent the activation of S100 pro-
teins, which consequently may lead to an amplification of
Hael-induced growth arrest and apoptosis. In support of
our assumption, RNAi-mediated knockdown of S100A4
has been reported to block cell growth and motility, and
to induce apoptosis in the human pancreatic cancer cell
lines BxPC-3, PANC-1 and MIA PaCa-2 via activation of
pro-apoptotic signaling proteins including caspase-3, and
caspase-9 [44, 45]. Similarly, in cardiac fibroblasts, knock-
down of S100A4 has been found to significantly suppress
cell proliferation via increasing p53 expression, whereas
the effect on apoptosis has not been investigated [46].
In summary, our results demonstrate that 8 % Hael
exerted no cytotoxic effects on all PC cells investigated
as well as on fibroblasts. In addition, the results show
that 8 % Hael led to growth inhibition in the PC cells,
which was amplified by the inhibition of calpain activity
or by cytosolic Ca2+ binding with the exception of the
AR42J cells. In fibroblasts, Hael failed to induce growth
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Fig. 8 Effect of calpain inhibition and cytosolic Ca2+ binding on the proliferation of Haelan-treated carcinoma cells and fibroblasts. CAPAN-1 cells
(a), BxPC-3 cells (b), AR42J cells (c) and fibroblasts (d) were incubated with 8 % Haelan or vehicle in the presence or absence of the calpain inhibitor
PD150606 or the Ca2+ chelator BAPTA-AM. After 24 h, the proliferation was measured using the WST-1 assay. Inhibition of calpain activity or Ca2+
chelation induces an additional decrease in the proliferation of Haelan-treated CAPAN-1 and BxPC3 cells, but not in the AR42J cells. In fibroblasts,
Haelan fails to induce growth arrest, whereas calpain inhibition or binding of Ca2+ initiates this mechanism. The results are expressed as mean + SEM
(n = 6-12). *P < 0.05, ***P < 0.001, control vs. Haelan-treated cells, xP < 0.05, xxP < 0.01, xxxP < 0.001, Haelan-treated cells vs. cells treated with Haelan in
the presence of PD150606 or BAPTA-AM
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binding triggered this mechanism. Hael was also found
to cause apoptosis in the PC cell lines, which was further
amplified when the cells were treated with Hael in com-
bination with calpain inhibitor or Ca2+ chelator. Hael
also induced apoptosis in fibroblasts, but both inhibitors
had no apoptosis amplifying effect.
Conclusions
Although the precise mechanisms underlying Hael-
induced growth arrest and apoptosis in the presence or
absence of calpain inhibitor or Ca2+ binding compounds
have to be elucidated, the results suggest that these agents
may be suitable targets for the treatment of human PC.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HW designed the study, performed the statistical analysis and wrote the
manuscript. JR and KD performed the experiments. MW helped with the
biochemical analyses and improved the style of written English. All authors
read and approved the final manuscript.
Acknowledgement
The authors thank Dr. Gisela Sparmann and Saskia Krohn from the
Department of Internal Medicine for providing of the CAPAN-1 and BxPC-3
cell lines and for generating the fluorescence micrographs, respectively.
Received: 24 November 2014 Accepted: 18 June 2015
References
1. Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic
cancer across the world. HPB (Oxford). 2008;10:58–62.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics,
2008. CA Cancer J Clin. 2008;58:71–96.
3. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev
Pharmacol Toxicol. 2002;42:25–54.
4. Li M, Yu X, Guo H, Sun L, Wang A, Liu Q, et al. Bufalin exerts antitumor
effects by inducing cell cycle arrest and triggering apoptosis in pancreatic
cancer cells. Tumour Biol. 2014;35:2461–71.
5. Saif MW. Is there a role for herbal medicine in the treatment of pancreatic
cancer? JOP. 2008;10:403–7.
6. Zhang L, Wu C, Zhang Y, Liu F, Zhao M, Bouvet M, et al. Efficacy
comparison of traditional Chinese medicine LQ versus gemcitabine in a
mouse model of pancreatic cancer. J Cell Biochem. 2013;114:2131–7.
7. Kim SO, Kim MR. [6]-Gingerol prevents disassembly of cell junctions and
activities of MMPs in invasive human pancreas cancer cells through ERK/NF- κ B/
Snail signal transduction pathway. Evid Based Complement Alternat Med. 2013
(2013), Article ID 761852, 9 p. http://dx.doi.org/10.1155/2013/761852.
8. Singh RP, Agarwal R. Natural flavonoids targeting deregulated cell cycle
progression in cancer cells. Curr Drug Targets. 2006;7:345–54.
9. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention:
flavonoids and isoflavonoids. Pharmacol Ther. 2001;90:157–77.
10. Weng CJ, Yen GC. Flavonoids, a ubiquitous dietary phenolic subclass, exert
extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer
Metastasis Rev. 2012;31:323–51.
11. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Saito M, et al. Soy isoflavone
aglycones are absorbed faster and in higher amounts than their glucosides
in humans. Nutr. 2000;130:1695–9.
12. Choi EJ, Kim T, Lee MS. Pro-apoptotic effect and cytotoxicity of genistein and
genistin in human ovarian cancer SK-OV-3 cells. Life Sci. 2007;80:1403–8.
13. Xiao JX, Huang GQ, Geng X, Qiu HW. Soy-derived isoflavones inhibit HeLa
cell growth by inducing apoptosis. Plant Foods Hum Nutr. 2011;66:122–8.
14. Dong X, Xu W, Sikes RA, Wu C. Combination of low dose of genistein and
daidzein has synergistic preventive effects on isogenic human prostate
cancer cells when compared with individual soy isoflavone. Food Chem.
2013;141:1923–33.
15. Hsu A, Bray TM, Helferich WG, Doerge DR, Ho E. Differential effects of whole
soy extract and soy isoflavones on apoptosis in prostate cancer cells.
Exp Biol Med. 2010;235:90–7.
16. Klein A, He X, Roche M, Mallett A, Duska L, Supko JG, et al. Prolonged
stabilization of platinum-resistant ovarian cancer in a single patient
consuming a fermented soy therapy. Gynecol Oncol. 2006;100:205–9.
17. Leloup L, Wells A. Calpains as potential anti-cancer targets. Expert Opin Ther
Targets. 2011;15:309–23.
18. Jánossy J, Ubezio P, Apáti A, Magócsi M, Tompa P, Friedrich P. Calpain as a
multi-site regulator of cell cycle. Biochem Pharmacol. 2004;67:1513–21.
19. Nair V, Fams MS. Soy and cancer survivors: Dietary supplementation with
fermented soy nutraceutical, Haelan 951 in patients who survived terminal
cancers. In: Townsend letter for doctors & patients. 2004. p. 48–56.
20. Wang X, Clubbs EA, Bomser JA. Genistein modulates prostate epithelial cell
proliferation via estrogen- and extracellular signal-regulated kinase-dependent
pathways. J Nutr Biochem. 2006;17:204–10.
21. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of
genistein on the growth of estrogen receptor-positive human breast cancer
(MCF-7) cells in vitro and in vivo. Cancer Res. 1998;58:3833–38.
22. Murata M, Midorikawa K, Koh M, Umezawa K, Kawanishi S. Genistein and
daidzein induce cell proliferation and their metabolites cause oxidative DNA
damage in relation to isoflavone-induced cancer of estrogen-sensitive
organs. Biochemistry. 2004;43:2569–77.
23. Wang C, Kurzer MS. Phytoestrogen concentration determines effects
on DNA synthesis in human breast cancer cells. Nutr Cancer.
1997;28:236–47.
24. Hollande E, Fanjul M, Houti N, Faye JC, Courriere P. Expression of estrogen
receptors during growth of human pancreatic adenocarcinoma cells
(Capan-1)-relationship with differentiation. In Vitro Cell Dev Biol Anim.
1998;34:593–9.
25. Haczynski J, Tarkowski R, Jarzabek K, Slomczynska M, Wolczynski S, Magoffin
DA, et al. Human cultured skin fibroblasts express estrogen receptor alpha
and beta. Int J Mol Med. 2002;10:149–53.
26. Choi EJ, Lee BH. Evidence for genistein mediated cytotoxicity and apoptosis
in rat brain. Life Sci. 2004;75:499–509.
27. Jin Y, Wu H, Cohen EM, Wei J, Jin H, Prentice H, et al. Genistein and
daidzein induce neurotoxicity at high concentrations in primary rat
neuronal cultures. J Biomed Sci. 2007;14:275–84.
28. Büchler P, Gukovskaya AS, Mouria M, Büchler MC, Büchler MW, Friess H,
et al. Prevention of metastatic pancreatic cancer growth in vivo by
induction of apoptosis with genistein, a naturally occurring isoflavonoid.
Pancreas. 2003;26:264–73.
29. Choi EJ, Kim GH. The antioxidant activity of daidzein metabolites,
O‑desmethylangolensin and equol, in HepG2 cells. Mol Med Rep.
2014;9:328–32.
30. McCabe Jr MJ, Orrenius S. Genistein induces apoptosis in immature human
thymocytes by inhibiting topoisomerase-II. Biochem Biophys Res Commun.
1993;194:944–50.
31. Ye R, Bodero A, Zhou BB, Khanna KK, Lavin MF, Lees-Miller SP. The plant
isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent
manner. J Biol Chem. 2001;276:4828–33.
32. Vousden KH. Outcomes of p53 activation-spoilt for choice. J Cell Sci.
2006;119:5015–20.
33. Polkowski K, Mazurek AP. Biological properties of genistein. A review of in
vitro and in vivo data. Acta Pol Pharm. 2000;57:135–55.
34. Yakovlev AG, Di Giovanni S, Wang G, Liu W, Stoica B, Faden AI. BOK and
NOXA are essential mediators of p53-dependent apoptosis. J Biol Chem.
2004;279:28367–74.
35. Gonen H, Shkedy D, Barnoy S, Kosower NS, Ciechanover A. On the
involvement of calpains in the degradation of the tumor suppressor protein
p53. FEBS Lett. 1997;406:17–22.
36. Guan N, Korukonda R, Hurh E, Schmittgen TD, Donkor IO, Dalton JT.
Apoptosis induced by novel aldehyde calpain inhibitors in human tumor
cell lines. Int J Oncol. 2006;29:655–63.
37. Delmas C, Aragou N, Poussard S, Cottin P, Darbon JM, Manenti S. MAP
kinase-dependent degradation of p27Kip1 by calpains in choroidal
melanoma cells. Requirement of p27Kip1 nuclear export. J Biol Chem.
2003;278:12443–51.
38. Zhu W, Murtha PE, Young CY. Calpain inhibitor-induced apoptosis in human
prostate adenocarcinoma cells. Biochem Biophys Res Commun.
1995;214:1130–37.
Rothe et al. BMC Complementary and Alternative Medicine  (2015) 15:212 Page 12 of 13
39. Atencio IA, Ramachandra M, Shabram P, Demers GW. Calpain inhibitor 1
activates p53-dependent apoptosis in tumor cell lines. Cell Growth Differ.
2000;11:247–53.
40. Łopatniuk P, Witkowski JM. Conventional calpains and programmed cell
death. Acta Biochim Pol. 2011;58:287–96.
41. Chua BT, Guo K, Li P. Direct cleavage by the calcium-activated protease
calpain can lead to inactivation of caspases. J Biol Chem. 2000;275:5131–5.
42. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, et al. Functions of
S100 proteins. Curr Mol Med. 2013;13:24–57.
43. Chen H, Xu C, Jin Q, Liu Z. S100 protein family in human cancer. Am J
Cancer Res. 2014;4:89–115.
44. Tabata T, Tsukamoto N, Fooladi AA, Yamanaka S, Furukawa T, Ishida M, et al.
RNA interference targeting against S100A4 suppresses cell growth and
motility and induces apoptosis in human pancreatic cancer cells. Biochem
Biophys Res Commun. 2009;390:475–80.
45. Che P, Yang Y, Han X, Hu M, Sellers JC, Londono-Joshi AI, et al. S100A4
promotes pancreatic cancer progression through a dual signaling pathway
mediated by Src and focal adhesion kinase. Sci Rep. 2015;5:8453.
46. Tamaki Y, Iwanaga Y, Niizuma S, Kawashima T, Kato T, Inuzuka Y, et al.
Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially
through the modulation of p53 in cardiac fibroblasts. J Mol Cell Cardiol.
2013;57:72–81.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Rothe et al. BMC Complementary and Alternative Medicine  (2015) 15:212 Page 13 of 13
